Literature DB >> 18787392

Hexarelin: a multi-receptor peptide.

R Deghenghi.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18787392     DOI： 10.1007/BF03345625

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  17 in total

1.  The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction.

Authors:  A Tivesten; E Bollano; K Caidahl; V Kujacic; X Y Sun; T Hedner; A Hjalmarson; B A Bengtsson; J Isgaard
Journal:  Endocrinology       Date:  2000-01       Impact factor: 4.736

2.  CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart.

Authors:  V Bodart; M Febbraio; A Demers; N McNicoll; P Pohankova; A Perreault; T Sejlitz; E Escher; R L Silverstein; D Lamontagne; H Ong
Journal:  Circ Res       Date:  2002-05-03       Impact factor: 17.367

3.  Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test.

Authors:  M Gasperi; G Aimaretti; G Scarcello; G Corneli; C Cosci; E Arvat; E Martino; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

4.  Growth hormone secretagogue binding sites in peripheral human tissues.

Authors:  M Papotti; C Ghè; P Cassoni; F Catapano; R Deghenghi; E Ghigo; G Muccioli
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

5.  Hexarelin as a test of pituitary reserve in patients with pituitary disease.

Authors:  M Korbonits; G Kaltsas; L A Perry; A B Grossman; J P Monson; G M Besser; P J Trainer
Journal:  Clin Endocrinol (Oxf)       Date:  1999-09       Impact factor: 3.478

6.  Identification of a new G-protein-linked receptor for growth hormone secretagogues.

Authors:  S S Pong; L Y Chaung; D C Dean; R P Nargund; A A Patchett; R G Smith
Journal:  Mol Endocrinol       Date:  1996-01

7.  Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.

Authors:  V De Gennaro Colonna; G Rossoni; M Bernareggi; E E Müller; F Berti
Journal:  Eur J Pharmacol       Date:  1997-09-10       Impact factor: 4.432

8.  GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats.

Authors:  R Deghenghi; M M Cananzi; A Torsello; C Battisti; E E Muller; V Locatelli
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

9.  The growth hormone response to hexarelin in patients with different hypothalamic-pituitary abnormalities.

Authors:  M Maghnie; V Spica-Russotto; M Cappa; M Autelli; C Tinelli; P Civolani; R Deghenghi; F Severi; S Loche
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

10.  Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.

Authors:  A A Patchett; R P Nargund; J R Tata; M H Chen; K J Barakat; D B Johnston; K Cheng; W W Chan; B Butler; G Hickey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.